Julphar’ launches AED500 million rights issue

Julphar’ launches AED500 million rights issue
Julphar’ launches AED500 million rights issue

We show you our most important and recent visitors news details Julphar’ launches AED500 million rights issue in the following article

Hind Al Soulia - Riyadh - RAS AL KHAIMAH, UAE — Gulf Pharmaceutical Industries PSC (Julphar), one of the largest pharmaceutical manufacturers in the Middle East and Africa, announced Monday the launch of its AED 500 million rights issue as the company progresses on its ambitious turnaround plan.

The rights issue is set to improve the company’s capital position and debt profile and will provide the financial foundation for the successful implementation of the company’s medium-term growth strategy.

As part of its capital restructuring, which included a capital reduction of AED 503 million as an initial step, Julphar offers 500 million new shares with a nominal value of AED 1. Issued to existing shareholders, the new shares will provide investors with the same rights — including the right to receive all future dividends — as existing shares. The subscription period of the shares begins on June 29 and ends on July 12.

Commenting on the launch of the rights issue, Sheikh Saqer Humaid Al Qasimi, chairman of the Board, Julphar, said: “The rights issue is a key component of the transformation plan which I am confident will further help us fuel our growth agenda in the years to come.

“On this occasion, I would like to thank our shareholders for their continued trust and their confidence in our ability to strengthen Julphar’s operational and financial performance. Our business fundamentals are robust and we have the experience, capabilities and resources to unlock further growth potential in our core markets.”

The capital restructuring and the terms of the rights issue were approved by Julphar’s Board of Directors and shareholders at the company’s Annual General Assembly held in April 2020. The rights issue has also been approved by the Security and Commodities Authority (SCA) of the UAE.

“In the past few months, we have accelerated our transformation journey to reclaim Julphar’s leadership position in the MENA region,” said Dr. Essam Farouk, chief executive officer of Julphar.

“The AED 500 million rights issue is central to our turnaround strategy, which capitalizes on Julphar’s core competencies to strengthen our balance sheet and invest in sustainable growth opportunities, while creating sustainable shareholder value. We are working on several strategic initiatives to move us towards a cash positive position and bring Julphar back to profitability.”

In addition to improving its capital structure and balance sheet, the newly injected capital is expected to help expand Julphar’s operations in key markets including Saudi Arabia, Iraq and Egypt.

Earlier this year, Julphar announced the relaunch of over 80 products in both Saudi Arabia and Oman after the confirmation of its full compliance with Good Manufacturing Practices (GMP) through an inspection conducted by the Gulf Health Council (GHC) and the Saudi Food and Drug Authority (SFDA).

Julphar was established in 1980 and registered as a national UAE public shareholding company with a mission to provide a better quality of life for the people by delivering best in class solutions and real value through a wide range of products such as medicines, vaccines and consumer healthcare products. — SG


These were the details of the news Julphar’ launches AED500 million rights issue for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Saudi Gazette and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV The global economy begins a slow mend as COVID-19 eases unevenly
NEXT Finance shake-up with Saudi derivatives market to launch in Q3